Tearsheet

Ardent Health (ARDT)


Market Price (12/4/2025): $8.97 | Market Cap: $1.3 Bil
Sector: Health Care | Industry: Health Care Facilities

Ardent Health (ARDT)


Market Price (12/4/2025): $8.97
Market Cap: $1.3 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 9.1%, FCF Yield is 5.6%
Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 90%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Oncology Treatments, Show more.
 
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 13%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 9.1%, FCF Yield is 5.6%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Oncology Treatments, Show more.
2 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 90%

Valuation, Metrics & Events

ARDT Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are the key points for the approximate -30.1% stock movement for Ardent Health (ARDT) from August 31, 2025, to December 5, 2025: 1. Third Quarter 2025 Net Loss and Missed Earnings Expectations: Ardent Health reported a net loss of $23 million, or $0.17 per diluted share, for the third quarter of 2025. This result fell below analyst consensus estimates, which had projected earnings per share in the range of $0.41 to $0.52.

2. Downward Revision of Full-Year 2025 Adjusted EBITDA Guidance: The company significantly reduced its full-year 2025 adjusted EBITDA guidance to a range of $530 million to $555 million, a notable decrease from its prior forecast of $575 million to $615 million. This revised outlook, implying a 9% increase at the midpoint from 2024, signaled weakening financial expectations.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
ARDT Return------48%-48%
Peers Return13%5%9%-1%-12%-16%-6%
S&P 500 Return16%27%-19%24%23%17%112%

Monthly Win Rates [3]
ARDT Win Rate----40%40% 
Peers Win Rate15%15%15%10%6%25% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
ARDT Max Drawdown------52% 
Peers Max Drawdown-16%-0%-4%-5%-13%-16% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: ACHC, AMTU, AVG, MCTA, SRTA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/4/2025 (YTD)

How Low Can It Go

ARDT has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1100 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ardent Health (ARDT)

Better Bets than Ardent Health (ARDT)

Trade Ideas

Select past ideas related to ARDT. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
10.0%10.0%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.7%-7.7%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.9%6.9%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
11.5%11.5%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.9%8.9%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Ardent Health

Peers to compare with:

Financials

ARDTACHCAMTUAVGMCTASRTAMedian
NameArdent H.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Mkt Price8.8714.64---4.408.87
Mkt Cap1.21.3----1.3
Rev LTM6,1993,266---2543,266
Op Inc LTM432444----24432
FCF LTM108-347----20-20
FCF 3Y Avg85-252----32-32
CFO LTM302335---1302
CFO 3Y Avg249308----18249

Growth & Margins

ARDTACHCAMTUAVGMCTASRTAMedian
NameArdent H.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Rev Chg LTM10.0%4.6%---6.7%6.7%
Rev Chg 3Y Avg-9.0%---36.5%22.7%
Rev Chg Q11.9%4.4%---4.2%4.4%
QoQ Delta Rev Chg LTM2.9%1.1%---1.1%1.1%
Op Mgn LTM7.0%13.6%----9.6%7.0%
Op Mgn 3Y Avg5.8%16.2%----22.0%5.8%
QoQ Delta Op Mgn LTM0.4%-1.0%---3.0%0.4%
CFO/Rev LTM4.9%10.3%---0.5%4.9%
CFO/Rev 3Y Avg4.6%10.2%----8.9%4.6%
FCF/Rev LTM1.7%-10.6%----7.7%-7.7%
FCF/Rev 3Y Avg1.5%-7.8%----14.6%-7.8%

Valuation

ARDTACHCAMTUAVGMCTASRTAMedian
NameArdent H.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Mkt Cap1.21.3----1.3
P/S0.30.7----0.5
P/EBIT4.08.2----6.1
P/E7.520.9----14.2
P/CFO6.36.7----6.5
Total Yield13.3%4.8%----9.0%
Dividend Yield0.0%0.0%----0.0%
FCF Yield 3Y Avg--7.6%-----7.6%
D/E1.21.1----1.1
Net D/E0.91.0----1.0

Returns

ARDTACHCAMTUAVGMCTASRTAMedian
NameArdent H.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
1M Rtn-39.1%-29.1%----6.8%-29.1%
3M Rtn-31.0%-38.1%---5.3%-31.0%
6M Rtn-39.9%-35.3%-----37.6%
12M Rtn-47.3%-65.3%-----56.3%
3Y Rtn--82.9%-----82.9%
1M Excs Rtn-40.3%-30.4%----8.0%-30.4%
3M Excs Rtn-38.4%-44.1%---2.6%-38.4%
6M Excs Rtn-55.3%-50.8%-----53.0%
12M Excs Rtn-59.1%-79.0%-----69.1%
3Y Excs Rtn--156.2%-----156.2%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity2,753,446
Short Interest: % Change Since 10312025-0.4%
Average Daily Volume869,189
Days-to-Cover Short Interest3.17
Basic Shares Quantity140,374,892
Short % of Basic Shares2.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025806202510-Q 6/30/2025
3312025507202510-Q 3/31/2025
12312024227202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024814202410-Q 6/30/2024
123120237182024424B4 12/31/2023
123120183062019S-1/A 12/31/2018
1231201712212018S-1/A 12/31/2017